The DOI matches its Crossref record; 16 of the 16 references it cites were found in a registry or an index.
Prevalence and Economic Burden of Bronchiectasis
Abstract
In Brief We employed a retrospective cohort design to estimate the prevalence and economic burden of bronchiectasis. Data were obtained from the health-care claims processing systems of more than 30 US health plans (with a combined total of 5.6 million covered lives) and spanned the period January 1, 1999, to December 31, 2001. Study subjects consisted of all persons who were aged ≥18 years in 2001 and had diagnoses of bronchiectasis between 1999 and 2001; those with diagnoses of cystic fibrosis were excluded. For purposes of comparison, a cohort of persons without diagnoses of bronchiectasis was randomly selected and matched on age, sex, geographic region, and comorbid conditions. Prevalence of bronchiectasis ranged from 4.2 per 100,000 persons aged 18–34 years to 271.8 per 100,000 among those aged ≥75 years. Prevalence was higher among women than men at all ages. Persons with bronchiectasis averaged 2.0 (95% confidence interval 1.7–2.3) additional days in hospital, 6.1 (6.0–6.1) additional outpatient encounters, and 27.2 (25.0–29.1) more days of antibiotic therapy than those without the disorder in 2001; average total medical-care expenditures were $5681 ($4862–$6593) higher for bronchiectasis patients. Our findings suggest that over 110,000 persons in the United States may be receiving treatment for bronchiectasis, resulting in additional medical-care expenditures of $630 million annually. Little is known about the epidemiology and economic burden of bronchiectasis. The results of our study suggest that over 110,000 persons in the United States may be receiving treatment for this disorder, resulting in additional medical-care expenditures of $630 million annually.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Persons With Chronic Conditions: Their Prevalence and Costs
Hoffman, C. (1996) · JAMA · doi:10.1001/jama.1996.03540180029029 · Cited by 966
An Investigation into Causative Factors in Patients with Bronchiectasis
PASTEUR, M. C., HELLIWELL, S. M., HOUGHTON, S. J., WEBB, S. C., FOWERAKER, J. E., COULDEN, R. A., FLOWER, C. D., BILTON, D., & KEOGAN, M. T. (2000) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.162.4.9906120 · Cited by 684
Heart failure prevalence, incidence, and mortality in the elderly with diabetes
Bertoni, A. G., Hundley, W. G., Massing, M. W., Bonds, D. E., Burke, G. L., & Goff, D. C. (2004) · Diabetes Care · doi:10.2337/diacare.27.3.699 · Cited by 596
Barker, A. F. (2002) · New England Journal of Medicine · doi:10.1056/nejmra012519 · Cited by 551
Treatment of Idiopathic Bronchiectasis With Aerosolized Recombinant Human DNase I
O'Donnell, A. E., Barker, A. F., Ilowite, J. S., & Fick, R. B. (1998) · Chest · doi:10.1378/chest.113.5.1329 · Cited by 443
Comparing The National Economic Burden Of Five Chronic Conditions
Druss, B. G., Marcus, S. C., Olfson, M., Tanielian, T., Elinson, L., & Pincus, H. A. (2001) · Health Affairs · doi:10.1377/hlthaff.20.6.233 · Cited by 322
The Costs of Treating COPD in the United States
Strassels, S. A., Smith, D. H., Sullivan, S. D., & Mahajan, P. S. (2001) · Chest · doi:10.1378/chest.119.2.344 · Cited by 287
Clinical, Pathophysiologic, and Microbiologic Characterization of Bronchiectasis in an Aging Cohort
Nicotra, M. B., Rivera, M., Dale, A. M., Shepherd, R., & Carter, R. (1995) · Chest · doi:10.1378/chest.108.4.955 · Cited by 284
Prevalence and Costs of Major Depression Among Elderly Claimants With Diabetes
Finkelstein, E. A., Bray, J. W., Chen, H., Larson, M. J., Miller, K., Tompkins, C. P., Keme, A., & Manderscheid, R. W. (2003) · Diabetes Care · doi:10.2337/diacare.26.2.415 · Cited by 154
Cost of Alzheimer's Disease and Related Dementia in Managed‐Medicare
Gutterman, E. M., Markowitz, J. S., Lewis, B., & Fillit, H. M. (1999) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.1999.tb05228.x · Cited by 143
Cited by
Incidence and Prevalence of Idiopathic Pulmonary Fibrosis
Raghu, G., Weycker, D., Edelsberg, J., Bradford, W. Z., & Oster, G. (2006) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200602-163oc · Cited by 1,310
Self-citationBritish Thoracic Society guideline for non-CFbronchiectasis
Pasteur, M. C., Bilton, D., Hill, A. T., & on behalf of the British Thoracic Society Bronchiectasis (non-CF) Guideline Group (2010) · Thorax · doi:10.1136/thx.2010.136119 · Cited by 1,046
Quint, J. K., Millett, E. R. C., Joshi, M., Navaratnam, V., Thomas, S. L., Hurst, J. R., Smeeth, L., & Brown, J. S. (2016) · European Respiratory Journal · doi:10.1183/13993003.01033-2015 · Cited by 557
Non–Cystic Fibrosis Bronchiectasis
McShane, P. J., Naureckas, E. T., Tino, G., & Strek, M. E. (2013) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201303-0411ci · Cited by 372
Self-citationTrends in Bronchiectasis Among Medicare Beneficiaries in the United States, 2000 to 2007
Seitz, A. E., Olivier, K. N., Adjemian, J., Holland, S. M., & Prevots, D. R. (2012) · Chest · doi:10.1378/chest.11-2209 · Cited by 318
Metadata
- Authors
- Weycker, D., Edelsberg, J., Oster, G., & Tino, G.
- Venue
- Clinical Pulmonary Medicine
- Published
- 2005-07
- Volume
- 12
- Issue
- 4
- Pages
- 205-209
- ISSN
- 1068-0640 (ISSN-L)
- OpenAlex
- W2053760924
- Cited by
- 327
- References
- 16
- FWCI
- 4.19
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Prevalence and Economic Burden of Bronchiectasis. https://app.cochat.ai/papers/10.1097/01.cpm.0000171422.98696.ed
- The paper
- Weycker, D., Edelsberg, J., Oster, G., & Tino, G. (2005). Prevalence and Economic Burden of Bronchiectasis. Clinical Pulmonary Medicine. https://doi.org/10.1097/01.cpm.0000171422.98696.ed
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.